MAY 30, 2017 9:00 AM PDT

Protein and Cell Analysis Education Series featuring the Antibody Validation Forum

  • Aled Edwards, PhD

    CEO, Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada; International Working Group for Antibody Validation (IWGAV) member
  • Matt Baker

    Director of Strategy and Partnering for Antibodies and Immunoassay, Biosciences Division, Thermo Fisher Scientific
  • Anita Bandrowski, PhD

    Scientific Lead, Neuroscience Information Framework, Center for Research in Biological Systems, University of California at San Diego, San Diego, California, USA; Founder and CEO of SciCrunc
  • Paul K. Wallace, PhD

    Professor of Oncology, and Director, Flow and Image Cytometry Facility, Roswell Park Cancer Institute, Buffalo, NY, USA; Associate Professor of Pathology, State University of New York at Buff
  • John Rogers, PhD

    Senior R&D Manager, Mass Spectrometry Reagents, Protein and Cell Analysis, Biosciences Division, Thermo Scientific
  • Christoph Hergersberg, PhD

    Vice President of R&D for Protein and Cell Analysis, and Antibodies and Immunoassays, Biosciences Division, Thermo Fisher Scientific


Addressing the antibody reproducibility crisis: A panel discussion with key scientific leaders


Reproducibility and antibody validation standards are two significant challenges facing scientific researchers today.  To address these issues, Thermo Fisher Scientific—a leading producer of antibodies— organized and supported a group of leading researchers from several global institutions. This International Working Group for Antibody Validation (IWGAV) brainstormed and developed a set of proposed standards to optimize antibody validation methods with a specific emphasis on antibody specificity verification.  As a follow up, in fall 2016, the Global Biological Standards Institute (GBSI) hosted a meeting attended by several IWGAV members and representatives from antibody producers, pharmaceutical companies and leading academic research labs. Attendees reviewed and validated the IWGAV proposed standards and discussed strategies designed to implement these standards across the industry.  


In this event, Thermo Fisher Scientific will host a live, virtual round table discussion in which representative IWGAV members and others from the research community will participate in a dialogue about antibody validation standards and practices, with the goal of finding consensus for how to further methods for verifying antibodies used for common laboratory techniques—such as western blotting, ELISA, immunohistochemistry, immunofluorescence. The panel will also discuss how these new standards may be adapted to validate antibodies intended for flow cytometry.




Time: 10:00 AM PDT

Antibody validation with immunoprecipitation/mass spectrometry and orthogonal methods (Login here)

Speaker: John Rogers, PhD, Thermo Fisher Scientific



Time: 11:00 AM PDT

Super Bright antibody conjugates for flow cytometry—Bright polymer dyes for the violet laser (Login here)

Speaker: Castle Funatake, PhD, Thermo Fisher Scientific



Time: 12:00 PM PDT

Chemiluminescent western blot detection: Bright and bold detection no matter how scarce your target (Login here)

Speaker: Emily Halbrader, Thermo Fisher Scientific



Time: 1:00 PM PDT

The new generation in immunoassays (Login here)

Speaker: David Bourdon, PhD, Thermo Fisher Scientific


You May Also Like
MAY 30, 2017 9:00 AM PDT

Protein and Cell Analysis Education Series featuring the Antibody Validation Forum

Loading Comments...